SCHEMBL19953972

SCHEMBL19953972

Cc1cc(C(C)(C)C)n(C2COC2)n1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24816290 0.87 CNR2 (0.37) CNR2
SCHEMBL19953969 0.83 TGFBR1 (0.40) CNR2
SCHEMBL19953968 0.81 KDM4E (0.39)
SCHEMBL25745819 0.81 MEN1 (0.31) MEN1KMT2A
SCHEMBL25745817 0.81 KDM4E (0.42)
SCHEMBL25745828 0.79 KDM4E (0.44)
SCHEMBL19954623 0.79 CYP1A2 (0.32) CNR2
SCHEMBL24007024 0.76 CNR1 (0.40) CNR2
SCHEMBL24816266 0.75
SCHEMBL28627037 0.75 POLB (0.38) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914706-B2 N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-13 US disclosed